ArticleMolecular oncology2023

Early circulating tumor DNA dynamics as a pan-tumor biomarker for long-term clinical outcome in patients treated with durvalumab and tremelimumab.

Maya Kansara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.